The Regulation of gene expression in Chlamydia
衣原体基因表达的调控
基本信息
- 批准号:6899867
- 负责人:
- 金额:$ 36.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-08-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:ChlamydiaceaeDNA directed RNA polymeraseDNA footprintingaffinity chromatographybacterial geneticsbioinformaticsdevelopmental geneticsfunctional /structural genomicsgel mobility shift assaygene mutationgenetic regulationgenetic regulatory elementgenetic transcriptionheat shock proteinsmicroarray technologyprotein purificationtranscription factor
项目摘要
DESCRIPTION (provided by applicant): Chlamydia is the leading cause of sexually transmitted disease in the developed world, and preventable blindness in the developing world. Our long-term goal is to define the molecular mechanisms that regulate chlamydial gene expression so that we may intervene during the organism's intracellular developmental cycle. Our central hypothesis is that chlamydial gene expression is coordinately regulated at the transcriptional level by master regulatory molecules, such as activators and repressors, and by alternative forms of RNA polymerase. We propose three aims:
1) Investigate the function of a cis-acting DNA element that is important for Chlamydia-specific promoter activity. We will use biochemical and physical approaches to determine if a novel DNA element called the Spacer A/T region exerts its positive effect on transcription by binding an activator.
2) Define the role of HrcA, a transcription factor that regulates the expression of heat shock genes. We will determine how heat shock gene expression is regulated by the physical state of the HrcA repressor, higher temperature, DNA topology, and by the heat shock protein, GroEL.
3) Define the role of sigma28 RNA polymerase, an alternative RNA polymerase. We will use functional, bioinformatics and DNA microarray approaches to identify sigma28 promoters and sigma28-regulated genes.
描述(由申请人提供):衣原体是发达国家性传播疾病的主要原因,并且是发展中国家的可预防失明。我们的长期目标是定义调节衣原体基因表达的分子机制,以便我们可以在生物体的细胞内发育周期中进行干预。我们的中心假设是,衣原体基因表达是由主调节分子(例如激活剂和抑制剂)以及RNA聚合酶的替代形式在转录水平上协调调节的。我们提出了三个目标:
1)研究对衣原体特异性启动子活性很重要的顺式作用DNA元件的功能。 我们将使用生化和物理方法来确定一种新型的DNA元素是否通过结合激活剂来对转录产生对转录的积极作用。
2)定义HRCA的作用,HRCA是调节热休克基因表达的转录因子的作用。我们将确定热休克基因表达如何受HRCA阻遏物,较高温度,DNA拓扑的物理状态以及热休克蛋白Groel调节。
3)定义Sigma28 RNA聚合酶(一种替代RNA聚合酶)的作用。我们将使用功能性,生物信息学和DNA微阵列方法来鉴定Sigma28启动子和SigMA28调节的基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ming Tan其他文献
Ming Tan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ming Tan', 18)}}的其他基金
A Nanoparticle-Based Multivalent Rotavirus Vaccine
基于纳米颗粒的多价轮状病毒疫苗
- 批准号:
10206373 - 财政年份:2020
- 资助金额:
$ 36.78万 - 项目类别:
Three-dimensional analysis and modeling of the Chlamydia developmental cycle
衣原体发育周期的三维分析和建模
- 批准号:
9207413 - 财政年份:2016
- 资助金额:
$ 36.78万 - 项目类别:
Three-dimensional analysis and modeling of the Chlamydia developmental cycle
衣原体发育周期的三维分析和建模
- 批准号:
9035928 - 财政年份:2016
- 资助金额:
$ 36.78万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
8233299 - 财政年份:2011
- 资助金额:
$ 36.78万 - 项目类别:
Norovirus P Particle, A Multifunctional Platform For Vaccine Development
诺如病毒粒子,疫苗开发的多功能平台
- 批准号:
8264954 - 财政年份:2011
- 资助金额:
$ 36.78万 - 项目类别:
Norovirus P Particle, A Multifunctional Platform For Vaccine Development
诺如病毒粒子,疫苗开发的多功能平台
- 批准号:
8190929 - 财政年份:2011
- 资助金额:
$ 36.78万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
9059029 - 财政年份:2011
- 资助金额:
$ 36.78万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
8448286 - 财政年份:2011
- 资助金额:
$ 36.78万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
8616726 - 财政年份:2011
- 资助金额:
$ 36.78万 - 项目类别: